The majority of human
melanoma cell lines secretes
vascular endothelial growth factor-A (
VEGF-A) and expresses its receptors
VEGFR-1,
VEGFR-2 and
neuropilin-1 (NRP‑1), a co-receptor for
VEGF-A that amplifies the signalling through
VEGFR-2. Since it is known that the
VEGF-A/VEGFR-2 autocrine loop promotes
melanoma cell invasiveness, the aim of the present study was to investigate the involvement of NPR-1 in
melanoma progression. Syngeneic human
melanoma cell lines expressing either
VEGFR-2 or NRP-1, both or none of them, were analyzed for their in vitro ability to migrate, invade the extracellular matrix (ECM) and secrete active metalloproteinase-2 (MMP-2). The results indicate that NRP-1 cooperates with
VEGFR-2 in
melanoma cell migration induced by
VEGF-A. Moreover, NRP-1 expression is sufficient to promote MMP-2 secretion and
melanoma cell invasiveness, as demonstrated by the ability of cells expressing solely NRP-1 to spontaneously invade the ECM. This ability is specifically downregulated by anti-NRP-1
antibodies or by interfering with NRP-1 expression using an
shRNA construct. Investigation of the signal transduction pathways triggered by NRP-1 in
melanoma cells, indicated that NRP-1-dependent promotion of cell invasiveness involves Akt activation through its phosphorylation on T308. Overall, the results demonstrate that NRP-1 is involved in
melanoma progression through VEGFR-2-dependent and -independent mechanisms and suggest NRP-1 as a target for the treatment of the metastatic disease.